<bill session="106" type="h" number="1109" updated="2013-07-14T18:53:22-04:00">
  <state datetime="1999-03-15">REFERRED</state>
  <status>
    <introduced datetime="1999-03-15"/>
  </status>
  <introduced datetime="1999-03-15"/>
  <titles>
    <title as="introduced" type="short">Medicare Outpatient Prescription Drug Coverage Act of 1999</title>
    <title as="introduced" type="official">To amend title XVIII of the Social Security Act to provide for coverage of outpatient prescription drugs under part B of the Medicare Program, and for other purposes.</title>
  </titles>
  <sponsor id="400122"/>
  <cosponsors>
    <cosponsor id="400003" joined="1999-03-15"/>
    <cosponsor id="400526" joined="1999-06-22"/>
    <cosponsor id="400087" joined="1999-03-15"/>
    <cosponsor id="400133" joined="1999-04-22"/>
    <cosponsor id="400143" joined="1999-06-14"/>
    <cosponsor id="400163" joined="1999-06-09"/>
    <cosponsor id="400502" joined="1999-04-20"/>
    <cosponsor id="400178" joined="1999-04-12"/>
    <cosponsor id="400208" joined="1999-04-20"/>
    <cosponsor id="400227" joined="2000-03-16"/>
    <cosponsor id="400537" joined="1999-04-15"/>
    <cosponsor id="400251" joined="1999-06-16"/>
    <cosponsor id="400257" joined="1999-03-15"/>
    <cosponsor id="400268" joined="1999-06-14"/>
    <cosponsor id="400271" joined="1999-04-22"/>
    <cosponsor id="400289" joined="1999-03-15"/>
    <cosponsor id="400295" joined="1999-06-14"/>
    <cosponsor id="400306" joined="1999-03-15"/>
    <cosponsor id="400312" joined="2000-03-08"/>
    <cosponsor id="400333" joined="2000-03-30"/>
    <cosponsor id="400350" joined="1999-03-15"/>
    <cosponsor id="400402" joined="1999-05-19"/>
    <cosponsor id="400416" joined="1999-06-09"/>
    <cosponsor id="400426" joined="1999-03-15"/>
    <cosponsor id="400438" joined="1999-03-15"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1999-03-15">
      <text>Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="1999-03-15">
      <text>Referred to House Commerce</text>
    </action>
    <action datetime="1999-03-15">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="1999-03-23">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="1999-04-07">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Ambulatory care"/>
    <term name="Auditing"/>
    <term name="Business records"/>
    <term name="Coinsurance"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Consumer education"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug interactions"/>
    <term name="Drug therapy"/>
    <term name="Drugs"/>
    <term name="Drugstores"/>
    <term name="Economics and public finance"/>
    <term name="Electronic data interchange"/>
    <term name="Emblems"/>
    <term name="Federal advisory bodies"/>
    <term name="Financial statements"/>
    <term name="Fines (Penalties)"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publications"/>
    <term name="Government publicity"/>
    <term name="Government statistics"/>
    <term name="Health counseling"/>
    <term name="Health education"/>
    <term name="Health insurance"/>
    <term name="Health insurance industry"/>
    <term name="Health maintenance organizations"/>
    <term name="Immunosuppressive drugs"/>
    <term name="Law"/>
    <term name="Mail-order business"/>
    <term name="Managed care"/>
    <term name="Medical economics"/>
    <term name="Medical fees"/>
    <term name="Medical records"/>
    <term name="Medical statistics"/>
    <term name="Medicare"/>
    <term name="Medicare fraud"/>
    <term name="Medicare managed care"/>
    <term name="Medication abuse"/>
    <term name="Medigap"/>
    <term name="Pharmacists"/>
    <term name="Physicians"/>
    <term name="Prescription pricing"/>
    <term name="Science, technology, communications"/>
    <term name="Signs and symbols"/>
    <term name="Social welfare"/>
    <term name="Standards"/>
    <term name="Surveys"/>
  </subjects>
  <amendments/>
  <summary>3/15/1999--Introduced.
Medicare Outpatient Prescription Drug Coverage Act of 1999 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to, among other things: (1) provide for coverage of certain outpatient prescription drugs; (2) outline payment rules, which include use of a standard claims form developed by the Secretary of Health and Human Services for use in requesting payment, and related requirements for drugs, including rules governing deductible amounts, providing for treatment of certain cost-based prepaid organizations under Medicare part C (Medicare+Choice), and prescribing an electronic claims system to be established by the Secretary; (3) establish an enforcement mechanism governing participating pharmacies dispensing covered outpatient prescription drugs, providing for civil money penalties in appropriate cases; (4) prohibit payment from being made under Medicare part B (Supplementary Medical Insurance) for any expense incurred for a covered outpatient drug dispensed in excess of a certain quantity, generally 30 days; and (5) direct the Director of the Congressional Office of Technology Assessment (sic) to provide for appointment of a Prescription Drug Payment Review Commission to report annually to Congress on drug payment determinations under this Act. Authorizes appropriations.</summary>
</bill>
